Recent Updates
Recently added Catalysts
ESTA Positive Sentiment

Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants

Key Takeaway: Establishment Labs Holdings Inc. presented new clinical data on Breast Tissue Preservation at the 11th World Symposium on Ergonomic Implants. The company also announced extensions to its product lines, Mia® and Preservé™, which now include new sizes and supporting tools. This highlights their commitment to advancing women's health and wellness.

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation of new clinical data supporting Breast Tissue Preservation.
  • Introduction of new product sizes and supporting tools for Mia® and Preservé™.
  • Focus on improving women's health and wellness in breast aesthetics.

Full Press Release Details

NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced the presentation of new clinical and scientific data supporting Breast Tissue Preservation and its Minimally Invasive Platform. Establishment Labs also announced the product line extensions of both Mia® and Preservé™ with new sizes and supporting tools. The announcements

Frequently Asked Questions

What did Establishment Labs present at the symposium?

They presented new clinical data supporting Breast Tissue Preservation.

What new products were announced by Establishment Labs?

They announced extensions to the Mia® and Preservé™ product lines.

What is the focus of Establishment Labs?

The company is dedicated to improving women's health and wellness.

Last updated: Sep 21, 2026